(Q115704760)

English

The Efficacy of Paxlovid against COVID-19 is the Result of the Tight Molecular Docking between Mpro and Antiviral Drugs (Nirmatrelvir and Ritonavir)

scholarly article

In more languages

edit

Statements

instance of

preprint

0 references

title

The Efficacy of Paxlovid against COVID-19 is the Result of the Tight Molecular Docking between Mpro and Antiviral Drugs (Nirmatrelvir and Ritonavir) (English)

0 references

author name string

Ali Adel Dawood

affiliation string

University of Mosul

series ordinal

1

0 references

reviewed by

Christopher VanLang

point in time

16 March 2023

0 references

0 references

language of work or name

0 references

22 July 2022

WikiJournal Preprints

organizer

WikiJournal of Science

0 references

rejection

point in time

17 March 2023

0 references

published in

WikiJournal Preprints

0 references

copyright license

Creative Commons Attribution 4.0 International

0 references

peer review URL

https://en.wikiversity.org/wiki/Talk:WikiJournal_Preprints/Treating_COVID-19_using_Non-coding_RNA:_A_Review_Article

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(1 entry)

enwikiversity WikiJournal Preprints/The Efficacy of Paxlovid against COVID-19 is the Result of the Tight Molecular Docking between Mpro and Antiviral Drugs (Nirmatrelvir and Ritonavir)

(Q115704760)

The Efficacy of Paxlovid against COVID-19 is the Result of the Tight Molecular Docking between Mpro and Antiviral Drugs (Nirmatrelvir and Ritonavir)

Statements

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(1 entry)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)